Gold tier: mechanically validated evidence, with its primary source.
956 evidence items · page 10 / 39
97 %In children who received RTS,S/AS01E vaccine in Burkina Faso and Mali, 97% showed a 2-fold increase in anti-CSP IgG antibody titres post-2018 as measured by Oxford MSD assay.
Burkina Faso · Malipaludismeobserved post-2018HAL · Unilimdocument of 105 observations
59 %Prevalence of past placental malaria infection was 59%.
Burkina Fasopaludismepublished 2021Maternal & child nutritioneurope_pmcdocument of 11 observations
50 %Almost 50% of alternative causes of fever were diagnosed by laboratory testing in the RDT false positive malaria group among febrile children under 5 years of age in Burkina Faso in 2015.
Burkina Fasopaludismeobserved 2015published 2017Malaria journaleurope_pmcdocument of 9 observations
66 %Malaria infection prevalence was estimated at 66% according to microscopy in under five children nationwide in Burkina Faso.
Burkina Fasopaludismepublished 2014Malaria journaleurope_pmcdocument of 7 observationsDOI 10.1186/1475-2875-13-101
7.3 %ENT symptoms were present in 7.3% of malaria patients among 306 febrile adults travelling in Burkina Faso.
Burkina FasopaludismeHAL · Unilimdocument of 83 observations
3 casesESBL positive non-typhoid Salmonella (n = 3) were detected in Burkina Faso only.
Burkina FasoESBL positive non-typhoid Salmonellaobserved November 2013 to March 2017published 2020Frontiers in microbiologyeurope_pmcdocument of 12 observations
69.5 %Plasmodium falciparum malaria was diagnosed in 69.5% of 683 febrile children under 5 years of age by RDT-PfHRP2 in Burkina Faso in 2015.
Burkina Fasopaludismeobserved 2015published 2017Malaria journaleurope_pmcdocument of 9 observations
0 %Among HIV-negative women, Ureaplasma urealyticum colonization was identified in 0.0%.
Burkina FasoUreaplasma urealyticum colonizationpublished 2011Journal of infection in developing countrieseurope_pmcdocument of 12 observationsDOI 10.3855/jidc.950
99.2 %Pyronaridine-artesunate had an efficacy of 99.2% for adequate clinical and parasitologic response on day 28 in the per-protocol population.
Burkina Fasopaludismepublished 2012The New England journal of medicineeurope_pmcdocument of 5 observationsDOI 10.1056/nejmoa1007125
42.4 %Baba et al. (2020) reported a reduction in deaths during high transmission of 42.4% in Burkina Faso and 56.6% in Gambia.
Burkina Fasopaludismeobserved 2020HAL · Unilimdocument of 110 observations
52.5 %In the 6 months-4 years age group, Plasmodium falciparum prevalence assessed using microscopy was 52.5% in Nanoro, Burkina Faso.
Burkina Fasopaludismepublished 2017Malaria journaleurope_pmcdocument of 16 observations
43.6 %In Nanoro, Burkina Faso, the prevalence of Pfdhfr triple mutations (CIRNI) rose from 43.6% pre-SMC to 89.4% post-SMC.
Burkina Fasopaludismeobserved 2010-2012published 2024Scientific reportsPubMeddocument of 4 observations
264 per_100000Le taux de mortalité maternelle était de 264 pour 100 000 naissances vivantes au Burkina Faso en 2020.
Burkina Fasomortalité maternelleobserved 2020HAL · Unilimdocument of 602 observations
27.2 %In children who received RTS,S/AS01E vaccine in Burkina Faso and Mali, 27.2% showed a 10-fold increase in anti-CSP IgG antibody titres post-2018 as measured by GSK ELISA.
Burkina Faso · Malipaludismeobserved post-2018HAL · Unilimdocument of 105 observations
0.07 hazard_ratioIgG avidity to C-terminus is significantly associated with vaccine efficacy (hazard ratio 0.07 [95% confidence interval 0.05–0.90]).
Burkina Fasopaludismepublished 2019Nature communicationseurope_pmcdocument of 6 observations
23.617 minutesThe mean duration of swarming was 23 minutes and 37 seconds for Anopheles gambiae.
Burkina Fasopaludismepublished 2013Parasites & vectorseurope_pmcdocument of 7 observationsDOI 10.1186/1756-3305-6-275
34.2 %The dhps A437G mutation was found in 34.2% of 231 successfully genotyped samples from pregnant women in Nanoro, Burkina Faso.
Burkina Fasopaludismeobserved 2010published 2015PloS oneeurope_pmcdocument of 8 observations
59 %The dominant vector species was An. gambiae s.l. (> 59%).
Burkina FasopaludismeHAL · Unilimdocument of 87 observations
64.7 %The negative predictive value (NPV) of PCT at 0.5 ng/ml for detection of bacteremia in patients aged ≥ 5 years was 64.7%.
Burkina Fasobacteraemiapublished 2021PLoS neglected tropical diseaseseurope_pmcdocument of 11 observations
94 %The diagnostic tests (HRP2-based RDT, QBC-test, and thick and thin blood film examinations) yielded coincident results in 94% of the patients (289/306).
Burkina FasopaludismeHAL · Unilimdocument of 83 observations
35.7 %The dhfr double mutations NRNI had a prevalence of 35.7% among 255 successfully genotyped samples from pregnant women in Nanoro, Burkina Faso.
Burkina Fasopaludismeobserved 2010published 2015PloS oneeurope_pmcdocument of 8 observations
0.35 p-valueNo significant differences in congenital malformations were found between treatment arms (p = 0.35).
Burkina Fasocongenital malformationspublished 2019Malaria journaleurope_pmcdocument of 6 observations
16.7 %Among HIV-positive women, Mycoplasma hominis colonization was identified in 16.7%.
Burkina FasoMycoplasma hominis colonizationpublished 2011Journal of infection in developing countrieseurope_pmcdocument of 12 observationsDOI 10.3855/jidc.950
The ace-1(R) mutation was absent in Anopheles arabiensis populations from south-western Burkina Faso.
Burkina Fasoinsecticide resistancepublished 2008The American journal of tropical medicine and hygieneeurope_pmcdocument of 3 observationsDOI 10.4269/ajtmh.2008.78.298
10 %Less than 10% of malaria parasites had matched circumsporozoite protein alleles in this trial.
Burkina Fasopaludismepublished 2015The New England journal of medicineeurope_pmcdocument of 5 observationsDOI 10.1056/nejmoa1505819
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.